Role of Interleukin-2 in the Treatment of Cancer Patients

Preface. 1. Introduction; J. Wagstaff. 2. Interleukin-2 as a single Agent: Dose, Scheduling and Optimum Immunomodularity Dose; L.M. Jost, R.A. Stahel. 3. Interleukin-2 and Lymphokine Activated Killer (LAK) Cells; S. Negrier, T.P. Philip. 4. Interleukin-2 Toxicity: Mechanisms and Management; J.W. Baars. 5. Interleukin-2: Biology and Immunology; G. Parmiani, C. Gambacorti-Passerini. 6. Interleukin-2 and Tumour Eradication by Cytotoxic T Lymphocytes; C.J.M. Melief, W.M. Kast. 7. Combination Treatment with Interleukin-2 and Chemotherapeutic Agents; A. von Rohr, N. Thatcher. 8. Interleukin-2, Lymphocytes and Monoclonal Antibodies; R.L.H. Bolhuis, G. Stoter. 9. Interleukin-2 and Other Cytokines; J. Atzpodien. 10. Future Prospects for Interleukin-2 Therapy; C.R. Franks, P.R. Palmer. Index.